116 related articles for article (PubMed ID: 22573733)
1. Fragment screening using capillary electrophoresis (CEfrag) for hit identification of heat shock protein 90 ATPase inhibitors.
Austin C; Pettit SN; Magnolo SK; Sanvoisin J; Chen W; Wood SP; Freeman LD; Pengelly RJ; Hughes DE
J Biomol Screen; 2012 Aug; 17(7):868-76. PubMed ID: 22573733
[TBL] [Abstract][Full Text] [Related]
2. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity.
Rowlands MG; Newbatt YM; Prodromou C; Pearl LH; Workman P; Aherne W
Anal Biochem; 2004 Apr; 327(2):176-83. PubMed ID: 15051534
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
[TBL] [Abstract][Full Text] [Related]
5. Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90.
Buchstaller HP; Eggenweiler HM; Sirrenberg C; Grädler U; Musil D; Hoppe E; Zimmermann A; Schwartz H; März J; Bomke J; Wegener A; Wolf M
Bioorg Med Chem Lett; 2012 Jul; 22(13):4396-403. PubMed ID: 22632933
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 inhibition with resorcyclic acid lactones (RALs).
Winssinger N; Fontaine JG; Barluenga S
Curr Top Med Chem; 2009; 9(15):1419-35. PubMed ID: 19860733
[TBL] [Abstract][Full Text] [Related]
7. 6-Alkylsalicylic acid analogues inhibit in vitro ATPase activity of heat shock protein 90.
Wu CZ; Moon AN; Choi O; Kang SY; Lee JJ; Lee D; Hwang BY; Kim YH; Lee HS; Hong YS
Arch Pharm Res; 2010 Dec; 33(12):1997-2001. PubMed ID: 21191765
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 inhibitors and drugs from fragment and virtual screening.
Roughley S; Wright L; Brough P; Massey A; Hubbard RE
Top Curr Chem; 2012; 317():61-82. PubMed ID: 21647838
[TBL] [Abstract][Full Text] [Related]
9. Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors.
Casale E; Amboldi N; Brasca MG; Caronni D; Colombo N; Dalvit C; Felder ER; Fogliatto G; Galvani A; Isacchi A; Polucci P; Riceputi L; Sola F; Visco C; Zuccotto F; Casuscelli F
Bioorg Med Chem; 2014 Aug; 22(15):4135-50. PubMed ID: 24980703
[TBL] [Abstract][Full Text] [Related]
10. ATPases as drug targets: insights from heat shock proteins 70 and 90.
Massey AJ
J Med Chem; 2010 Oct; 53(20):7280-6. PubMed ID: 20608738
[No Abstract] [Full Text] [Related]
11. C-terminal regions of Hsp90 are important for trapping the nucleotide during the ATPase cycle.
Weikl T; Muschler P; Richter K; Veit T; Reinstein J; Buchner J
J Mol Biol; 2000 Nov; 303(4):583-92. PubMed ID: 11054293
[TBL] [Abstract][Full Text] [Related]
12. Discovery and development of heat shock protein 90 inhibitors.
Taldone T; Sun W; Chiosis G
Bioorg Med Chem; 2009 Mar; 17(6):2225-35. PubMed ID: 19017562
[TBL] [Abstract][Full Text] [Related]
13. Fragment screening by weak affinity chromatography: comparison with established techniques for screening against HSP90.
Meiby E; Simmonite H; le Strat L; Davis B; Matassova N; Moore JD; Mrosek M; Murray J; Hubbard RE; Ohlson S
Anal Chem; 2013 Jul; 85(14):6756-66. PubMed ID: 23806099
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 regulates development in Dictyostelium discoideum.
Sawarkar R; Roy N; Rao S; Raman S; Venketesh S; Suguna K; Tatu U
J Mol Biol; 2008 Oct; 383(1):24-35. PubMed ID: 18718841
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
Wright L; Barril X; Dymock B; Sheridan L; Surgenor A; Beswick M; Drysdale M; Collier A; Massey A; Davies N; Fink A; Fromont C; Aherne W; Boxall K; Sharp S; Workman P; Hubbard RE
Chem Biol; 2004 Jun; 11(6):775-85. PubMed ID: 15217611
[TBL] [Abstract][Full Text] [Related]
16. Lead generation of heat shock protein 90 inhibitors by a combination of fragment-based approach, virtual screening, and structure-based drug design.
Miura T; Fukami TA; Hasegawa K; Ono N; Suda A; Shindo H; Yoon DO; Kim SJ; Na YJ; Aoki Y; Shimma N; Tsukuda T; Shiratori Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5778-83. PubMed ID: 21875802
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening for Hsp90 ATPase inhibitors.
Avila C; Hadden MK; Ma Z; Kornilayev BA; Ye QZ; Blagg BS
Bioorg Med Chem Lett; 2006 Jun; 16(11):3005-8. PubMed ID: 16530412
[TBL] [Abstract][Full Text] [Related]
18. Relationship among ligand conformations in solution, in the solid state, and at the Hsp90 binding site: geldanamycin and radicicol.
Thepchatri P; Eliseo T; Cicero DO; Myles D; Snyder JP
J Am Chem Soc; 2007 Mar; 129(11):3127-34. PubMed ID: 17323946
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HSP90 with pochoximes: SAR and structure-based insights.
Barluenga S; Fontaine JG; Wang C; Aouadi K; Chen R; Beebe K; Neckers L; Winssinger N
Chembiochem; 2009 Nov; 10(17):2753-9. PubMed ID: 19856365
[TBL] [Abstract][Full Text] [Related]
20. Assays for identification of Hsp90 inhibitors and biochemical methods for discriminating their mechanism of action.
Matts RL; Manjarrez JR
Curr Top Med Chem; 2009; 9(15):1462-78. PubMed ID: 19860729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
